Catalyst Wire Dossier Catalyst Wire Dossier

Elunate

fruquintinib · Hutchmed (China) Limited
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Elunate, covering 2024-10-10 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases [Phase 2]

See pricing